Drug Discovery and Development Analysis & Statistics, July 2014 (p30)

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

871-910 of about 3 300 reports

Purchase Reports From Reputable Market Research Publishers

Farnesoid X Receptor (FXR) Agonists -Pipeline Insights, 2014

Farnesoid X Receptor (FXR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Farnesoid X Receptor (FXR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Farnesyl Diphosphate Synthase (FPPS) Inhibitors -Pipeline Insights, 2014

Farnesyl Diphosphate Synthase (FPPS) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Farnesyl Diphosphate Synthase (FPPS) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Farnesyl Pyrophosphate (FPP) Inhibitors -Pipeline Insights, 2014

Farnesyl Pyrophosphate (FPP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Farnesyl Pyrophosphate (FPP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Farnesyltransferase Inhibitors (FTIs) -Pipeline Insights, 2014

Farnesyltransferase Inhibitors (FTIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Farnesyltransferase Inhibitors (FTIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Fast Skeletal Muscle Troponin Activators -Pipeline Insights, 2014

Fast Skeletal Muscle Troponin Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fast Skeletal Muscle Troponin Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Fc-Gamma Receptor Antagonist -Pipeline Insights, 2014

Fc-Gamma Receptor Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fc-Gamma Receptor Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Flagellin Inhibitors -Pipeline Insights, 2014

Flagellin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Flagellin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Focal Adhesion Kinase (FAK) Inhibitors -Pipeline Insights, 2014

Focal Adhesion Kinase (FAK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Focal Adhesion Kinase (FAK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Fusion Inhibitors -Pipeline Insights, 2014

Fusion Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fusion Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
G2 Checkpoint Inhibitors -Pipeline Insights, 2014

G2 Checkpoint Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“G2 Checkpoint Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Beta-1 Receptors  Antagonists -Pipeline Insights, 2014

Beta-1 Receptors Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta-1 Receptors Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Beta-2 Receptors  Antagonists -Pipeline Insights, 2014

Beta-2 Receptors Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta-2 Receptors Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors -Pipeline Insights, 2014

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Diglyceride Acyltransferase 1 (DGAT-1) Inhibitors -Pipeline Insights, 2014

Diglyceride Acyltransferase 1 (DGAT-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Diglyceride Acyltransferase 1 (DGAT-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Endothelin Receptor A (ETA) Antagonists -Pipeline Insights, 2014

Endothelin Receptor A (ETA) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Endothelin Receptor A (ETA) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Endothelin Receptor B (ETB) Antagonists -Pipeline Insights, 2014

Endothelin Receptor B (ETB) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Endothelin Receptor B (ETB) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
GABA Receptor Agonists -Pipeline Insights, 2014

GABA Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
GABA Receptor Antagonists -Pipeline Insights, 2014

GABA Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
GABA Receptor Modulators -Pipeline Insights, 2014

GABA Receptor Modulators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Receptor Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
GABA Transaminase Inhibitors -Pipeline Insights, 2014

GABA Transaminase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Transaminase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
GABAA Agonists -Pipeline Insights, 2014

GABAA Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAA Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
GABAA Modulators -Pipeline Insights, 2014

GABAA Modulators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAA Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
GABAB Agonists -Pipeline Insights, 2014

GABAB Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAB Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
GABAB Modulators -Pipeline Insights, 2014

GABAB Modulators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAB Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Gamma Secretase inhibitors -Pipeline Insights, 2014

Gamma Secretase inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Gamma Secretase inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ganglioside GD2 Inhibitors -Pipeline Insights, 2014

Ganglioside GD2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ganglioside GD2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ganglioside GD3 Inhibitors -Pipeline Insights, 2014

Ganglioside GD3 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ganglioside GD3 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ghrelin Receptor Agonists -Pipeline Insights, 2014

Ghrelin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ghrelin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ghrelin Receptor Antagonists -Pipeline Insights, 2014

Ghrelin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ghrelin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Glial-Derived Neurotrophic Factor (GDNF) Modulators -Pipeline Insights, 2014

Glial-Derived Neurotrophic Factor (GDNF) Modulators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glial-Derived Neurotrophic Factor (GDNF) Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development

83 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.